Authors: ROUGIER P VANCUTSEM E BAJETTA E NIEDERLE N POSSINGER K LABIANCA R NAVARRO M MORANT R BLEIBERG H WILS J AWAD L HERAIT P JACQUES C

Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412

Authors: CUNNINGHAM D PYRHONEN S JAMES RD PUNT CJA HICKISH TF HEIKKILA R JOHANNESEN TB STARKHAMMAR H TOPHAM CA AWAD L JACQUES C HERAIT P

Citation: D. Cunningham et al., RANDOMIZED TRIAL OF IRINOTECAN PLUS SUPPORTIVE CARE VERSUS SUPPORTIVECARE ALONE AFTER FLUOROURACIL FAILURE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1413-1418

Authors: WASSERMAN E MYARA A RIOFRIO M PAUMIER D HERAIT P AWAD L MISSET JL CVITKOVIC E

Citation: E. Wasserman et al., BILIRUBIN - BASE-LINE VALUE AND TRANSIENT INCREASE OF TOTAL BILIRUBIN(BIL) MAY BE USED AS GOOD PREDICTOR OF CPT-11S TOXICITY, European journal of cancer, 33, 1997, pp. 1110-1110